A method for polyclonal antigen-specific T cell-targeted genome editing (TarGET) for adoptive cell transfer applications.
Journal Information
Full Title: Mol Ther Methods Clin Dev
Abbreviation: Mol Ther Methods Clin Dev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the raw and processed scrna-seq data generated in this study will be deposited in the gene expression omnibus under accession number gse234778 ."
"Declaration of interests The authors declare no competing interests."
"We thank the Genomics Facility Basel and FACS Core facility of the Department of Biomedicine, University Hospital of Basel, for excellent support and assistance throughout this study. Acknowledgments go to the blood donors, and to Dr. Glenn Bantug for providing the EBV strain. This work was supported by the Swiss National Foundation Grant 32003B_204944 (to N.K.), NCCR Antiresist Grant No. 180541, Switzerland (to N.K.), Bangerter–Rhyner Stiftung (to N.K.), 10.13039/501100003006ETH Zurich Post-doctoral Fellowship, Switzerland (to R.B.D.R.), 10.13039/501100013850Helmut Horten Stiftung, Switzerland (to S.T.R.), and NCCR Molecular Systems Engineering, Switzerland (to S.T.R.)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025